Evidence map›Paper›PMID 42072215›Full record

ArticleBioengineering (Basel, Switzerland)2026

Personalized Simulation Modeling of Overlapping Microwave Ablation for Large Tumors.

Qi Wang, Shuicai Wu, Luyu Li, Xinnan Xue, Honghai Zhang, Weiwei Wu, Hongjian Gao

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qi WangCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China.
Shuicai WuCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China.
Luyu LiCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China.
Xinnan XueCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China.
Honghai ZhangBeijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Weiwei WuCollege of Biomedical Engineering, Capital Medical University, Beijing 100069, China.
Hongjian GaoCollege of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China.ORCID 0000-0002-9902-893X

Funding

Beijing Municipal Commission of Education KM202310025019National Natural Science Foundation of China 82171941
6 · The paper itself

Abstract

This paper evaluates the advantages of overlapping microwave ablation (OMWA) for the personalized treatment of large tumors, providing quantitative and technical references for conformal tumor eradication. A three-dimensional numerical model coupled with electromagnetic fields and Pennes' biological heat transfer equation was constructed, comprehensively considering the nonlinear behavior of tissue electrical and thermal parameters with temperature changes. A simulation model was developed to predict temperature distribution and the formation of the coagulation zone under single-needle multiple-point and multiple-needle multiple-point OMWA strategies. The LiTS2017 public dataset of liver tumor cases and real clinical cases was selected for verification. The results showed that OMWA could achieve faster thermal accumulation, higher central temperature, and more conformal tumor coverage. Compared with the single-needle strategy, OMWA significantly reduces thermal damage to surrounding healthy tissues while achieving complete tumor coverage. Therefore, OMWA is more efficient and safer than the single-needle strategy in the personalized treatment of large tumors and can provide important references for clinical preoperative planning and parameter optimization.

Indexed as

coagulation zonefinite element simulationlarge tumoroverlapping microwave ablationsingle-needle multi-point strategytrue anatomical structure

Identifiers

PMID42072215
PMCPMC13113720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.